Materials • Major Chemicals
$170.40 ▲ +4.10
(+2.47%)
MKT CAP: $5.41B • VOL: 196.2K
52W L $147 52W H $184
BCPC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.04B | $953.7M | $922.4M |
| YoY Revenue Growth % | +8.8% | +3.4% | — |
| Gross Profit | $370.6M | $336.2M | — |
| Gross Margin % | 35.7% | 35.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $209.3M | $182.9M | $159.2M |
| Operating Margin % | 20.2% | 19.2% | 17.3% |
| Net Income (GAAP) | $154.8M | $128.5M | $108.5M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $216.6M | $182.0M | $183.8M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $216.6M | $182.0M | $183.8M |
| FCF Margin % | 20.9% | 19.1% | 19.9% |
| Return on Invested Capital (ROIC %) | 14.0% | 13.1% | — |
| Cash & Short-Term Equivalents | $74.6M | $49.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.26B | $1.15B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BCPC.